Literature DB >> 20403086

Recovery from disrupted ultradian glucocorticoid rhythmicity reveals a dissociation between hormonal and behavioural stress responsiveness.

R A Sarabdjitsingh1, F Spiga, M S Oitzl, Y Kershaw, O C Meijer, S L Lightman, E R de Kloet.   

Abstract

Ultradian release of glucocorticoids is thought to be essential for homeostasis and health. Furthermore, deviation from this pulsatile release pattern is considered to compromise resilience to stress-related disease, even after hormone levels have normalised. In the present study, we investigate how constant exposure to different concentrations of corticosterone affects diurnal and ultradian pulsatility. The rate of recovery in pulsatile hypothalamic-pituitary-adrenal (HPA) activity after withdrawal of exogenous corticosterone is also examined. Finally, the behavioural and neuroendocrine responsiveness to an audiogenic stressor is studied. Adrenally intact male rats were subcutaneously implanted with vehicle, 40% or 100% corticosterone pellets for 7 days. The continuous release of corticosterone from these implants abolished diurnal and ultradian corticosterone variation, as measured with high-frequency automated blood sampling. Pellet removal on post-surgery day 8 allowed rapid recovery of endogenous rhythms in animals previously exposed to daily average concentrations (40%) but not after exposure to high concentrations (100%) of corticosterone. Behavioural and neuroendocrine responsiveness to stress was distinctly different between the treatment groups. Audiogenic stimulation 1 day after pellet removal resulted in a similar corticosterone response in animals previously exposed to 40% corticosterone or vehicle. The 40% pellet group, however, showed less and shorter behavioural activity (i.e. locomotion, risk assessment) to noise stress compared to 100% corticosterone and vehicle-treated animals. In conclusion, unlike the animals impanted with 100% corticosterone, we find that basal HPA axis activity in the 40% group, which had mean daily levels of circulating corticosterone in the physiological range, rapidly reverts to the characteristic pulsatile pattern of corticosterone secretion. Upon reinstatement of the ultradian rhythm, and despite the fact that these animals did not differ from controls in their response to noise stress, they did show substantial changes in their behavioural response to stress.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403086      PMCID: PMC4976802          DOI: 10.1111/j.1365-2826.2010.02004.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  52 in total

1.  On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.

Authors:  A Ratka; W Sutanto; M Bloemers; E R de Kloet
Journal:  Neuroendocrinology       Date:  1989-08       Impact factor: 4.914

Review 2.  The corticosteroid receptor hypothesis of depression.

Authors:  F Holsboer
Journal:  Neuropsychopharmacology       Date:  2000-11       Impact factor: 7.853

3.  Subtle cognitive impairments in patients with long-term cure of Cushing's disease.

Authors:  Jitske Tiemensma; Nieke E Kokshoorn; Nienke R Biermasz; Bart-Jan S A Keijser; Moniek J E Wassenaar; Huub A M Middelkoop; Alberto M Pereira; Johannes A Romijn
Journal:  J Clin Endocrinol Metab       Date:  2010-04-06       Impact factor: 5.958

Review 4.  Remodeling of neuronal networks by stress.

Authors:  Eberhard Fuchs; Gabriele Flugge; Boldizsar Czeh
Journal:  Front Biosci       Date:  2006-09-01

Review 5.  Chronic stress: implications for neuronal morphology, function and neurogenesis.

Authors:  Marian Joëls; Henk Karst; Harmen J Krugers; Paul J Lucassen
Journal:  Front Neuroendocrinol       Date:  2007-05-01       Impact factor: 8.606

6.  Everything has rhythm: focus on glucocorticoid pulsatility.

Authors:  E Ronald de Kloet; R Angela Sarabdjitsingh
Journal:  Endocrinology       Date:  2008-07       Impact factor: 4.736

7.  Constant corticosterone replacement normalizes basal adrenocorticotropin (ACTH) but permits sustained ACTH hypersecretion after stress in adrenalectomized rats.

Authors:  S F Akana; L Jacobson; C S Cascio; J Shinsako; M F Dallman
Journal:  Endocrinology       Date:  1988-04       Impact factor: 4.736

8.  Corticosterone: narrow range required for normal body and thymus weight and ACTH.

Authors:  S F Akana; C S Cascio; J Shinsako; M F Dallman
Journal:  Am J Physiol       Date:  1985-11

Review 9.  The significance of glucocorticoid pulsatility.

Authors:  Stafford L Lightman; Crispin C Wiles; Helen C Atkinson; David E Henley; Georgina M Russell; Jack A Leendertz; Mervyn A McKenna; Francesca Spiga; Susan A Wood; Becky L Conway-Campbell
Journal:  Eur J Pharmacol       Date:  2008-02-09       Impact factor: 4.432

10.  Diurnal variation in the responsiveness of the hypothalamic-pituitary-adrenal axis of the male rat to noise stress.

Authors:  H C Atkinson; S A Wood; Y M Kershaw; E Bate; S L Lightman
Journal:  J Neuroendocrinol       Date:  2006-07       Impact factor: 3.627

View more
  10 in total

1.  Stimulation of StAR expression by cAMP is controlled by inhibition of highly inducible SIK1 via CRTC2, a co-activator of CREB.

Authors:  Jinwoo Lee; Tiegang Tong; Hiroshi Takemori; Colin Jefcoate
Journal:  Mol Cell Endocrinol       Date:  2015-02-07       Impact factor: 4.102

Review 2.  Glucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress.

Authors:  Brent Myers; Jessica M McKlveen; James P Herman
Journal:  Front Neuroendocrinol       Date:  2013-12-18       Impact factor: 8.606

3.  The impact of regular lifestyle behavior in migraine: a prevalence case-referent study.

Authors:  Yohannes W Woldeamanuel; Robert P Cowan
Journal:  J Neurol       Date:  2016-01-25       Impact factor: 4.849

4.  Experience and activity-dependent control of glucocorticoid receptors during the stress response in large-scale brain networks.

Authors:  Damien Huzard; Virginie Rappeneau; Onno C Meijer; Chadi Touma; Margarita Arango-Lievano; Michael J Garabedian; Freddy Jeanneteau
Journal:  Stress       Date:  2020-08-26       Impact factor: 3.493

5.  The origin of glucocorticoid hormone oscillations.

Authors:  Jamie J Walker; Francesca Spiga; Eleanor Waite; Zidong Zhao; Yvonne Kershaw; John R Terry; Stafford L Lightman
Journal:  PLoS Biol       Date:  2012-06-05       Impact factor: 8.029

6.  Glucocorticoid Mechanisms of Functional Connectivity Changes in Stress-Related Neuropsychiatric Disorders.

Authors:  Baila S Hall; Rachel N Moda; Conor Liston
Journal:  Neurobiol Stress       Date:  2015-01-01

7.  Circadian glucocorticoid oscillations preserve a population of adult hippocampal neural stem cells in the aging brain.

Authors:  M Schouten; P Bielefeld; L Garcia-Corzo; E M J Passchier; S Gradari; T Jungenitz; M Pons-Espinal; E Gebara; S Martín-Suárez; P J Lucassen; H E De Vries; J L Trejo; S W Schwarzacher; D De Pietri Tonelli; N Toni; H Mira; J M Encinas; C P Fitzsimons
Journal:  Mol Psychiatry       Date:  2019-06-20       Impact factor: 15.992

8.  Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female mice.

Authors:  Maaike Schilperoort; Jan Kroon; Sander Kooijman; Annelies E Smit; Max Gentenaar; Kathrin Mletzko; Felix N Schmidt; Leo van Ruijven; Björn Busse; Alberto M Pereira; Natasha M Appelman-Dijkstra; Nathalie Bravenboer; Patrick C N Rensen; Onno C Meijer; Elizabeth M Winter
Journal:  Aging Cell       Date:  2021-09-30       Impact factor: 9.304

9.  Biphasic Response of Astrocytic Brain-Derived Neurotrophic Factor Expression following Corticosterone Stimulation.

Authors:  Alexandros Tsimpolis; Maria Kokkali; Aris Logothetis; Konstantinos Kalafatakis; Ioannis Charalampopoulos
Journal:  Biomolecules       Date:  2022-09-18

10.  Hippocampal Fast Glutamatergic Transmission Is Transiently Regulated by Corticosterone Pulsatility.

Authors:  R Angela Sarabdjitsingh; Natasha Pasricha; Johanna A S Smeets; Amber Kerkhofs; Lenka Mikasova; Henk Karst; Laurent Groc; Marian Joëls
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.